R&D Scaling fast-growing life sciences companies in the UK with ... Over the past few years, the life sciences industry has been accelerating at a rapid rate.
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
Market Access Global comparator data signal “alarm bells” for UK Governmen... Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI.
Views & Analysis Beyond Brexit: how the UK can continue to attract foreign in... The UK will remain a world-class place for life sciences, regardless of Brexit – but overseas companies can benefit from experienced guides on how to set up and thrive here, say Mark Edwards an
Views & Analysis Brexit life sciences ‘beauty contest’ underway How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.
Views & Analysis Why does UK biotech struggle to generate leaders? Can the UK emulate America's culture of biotech entrepreneurship?
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
